β-Hydroxyesters are essential building blocks utilised by the pharmaceutical and food industries in the synthesis of functional products. Beyond the conventional production methods based on chemical catalysis or whole-cell synthesis, the asymmetric reduction of β-ketoesters with cell-free enzymes is gaining relevance. To this end, a novel thermophilic (S)-3-hydroxybutyryl-CoA dehydrogenase from Thermus thermophilus HB27 (Tt27-HBDH) has been expressed, purified and biochemically characterised, determining its substrate specificity towards β-ketoesters and its dependence on NADH as a cofactor. The immobilization of Tt27-HBDH on agarose macroporous beads and its subsequent coating with polyethyleneimine has been found the best strategy to increase the stability and workability of the heterogeneous biocatalyst. Furthermore, we have embedded NADH in the cationic layer attached to the porous surface of the carrier. Since Tt27-HBDH catalyses cofactor recycling through 2-propanol oxidation, we achieve a self-sufficient heterogeneous biocatalyst where NADH is available for the immobilised enzymes but its lixiviation to the reaction bulk is avoided. Taking advantage of the autofluorescence of NADH, we demonstrate the activity of the enzyme towards the immobilised cofactor through single-particle analysis. Finally, we tested the operational stability in the asymmetric reduction of β-ketoesters in batch, succeeding in the reuse of both the enzyme and the co-immobilised cofactor up to 10 reaction cycles.
β-Hydroxy esters are essential building blocks utilised by the pharmaceutical and food industries in the synthesis of functional products. The asymmetric reduction of β-keto esters using cell-free enzymes presents a viable approach to manufacture enantiomerically pure β-hydroxy esters. However, the unbearable economic costs underlying enzymes and cofactors call for innovative approaches to maximise their reusability. Herein, we develop two self-sufficient Heterogeneous Biocatalysts (ssHBs) for the enantiodivergent reduction of β-keto esters to yield enantiomerically pure β-hydroxy esters. A thermophilic (S)-3-hydroxybutyryl-CoA dehydrogenase from Thermus thermophilus HB27 (TtHBDH) and an (R)-specific ketoreductase from Lactobacillus kefir (LkKRED) are selected, kinetically characterised, and immobilised onto macroporous agarose beads. Finally, the immobilised enzymes are coated with cationic polymers to co-immobilise the required redox cofactors. The resulting ssHBs catalyse the asymmetric reduction of β-keto esters without the exogenous supply of NAD(P)H and using 2-propanol as an ancillary electron donor. Then, we construct two enantiodivergent packed bed reactors (PBRs) integrating these two ssHBs and determine their optimal operational parameters through condition screening and kinetic simulations. The ssHBs in continuous flow operation exhibit good operational stability, illustrated by a maximum Space-Time Yield (STY) of 49.5 g L−1 h−1 for the continuous production of enantiopure ethyl 3-(R)-hydroxybutyrate over 21 days. Under these conditions, LkKRED and NADPH achieve total turnover numbers of 9.3 × 105 and 2.7 × 104, respectively. Upon mass metric analysis, we conclude that these ssHBs meet the efficiency and sustainability standards to be implemented in some industrial processes, advancing the concept of self-sufficient biocatalysis for process intensification.
Lecitase Ultra® solutions are mainly composed of bimolecular aggregates of two open structures of the enzyme. The immobilization and fixation of these bimolecular aggregates onto support surfaces is here proposed as a novel protocol for the immobilization and stabilization of Lecitase. The resulting derivatives of Lecitase aggregates were much more stable than the diluted solutions of the enzyme. The most stable of them was obtained by covalent immobilization of the bimolecular aggregate: 300-fold more stable than the diluted enzyme and 75-fold more stable than open Lecitase adsorbed onto hydrophobic supports. The bimolecular aggregate that adsorbed onto polyethyleneimine-agarose exhibited the best combination of activity and stability for the hydrolysis of krill oil. Omega-3 acids are in the sn-2 position of the krill oil, but they are also released by a phospholipase A1 because of migration issues.